Article in Medecine tropicale et sante internationale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 2 institutions in 2 countries.
Élisabeth RavaoarisoaUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
Voahangy Hanitriniaina Isabelle AndrianaranjakaUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
Aina David RamanantsahalaUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
Tovonahary Angelo RakotomangaUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
Fanomezantsoa RalinoroUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
Rianasoambolanoro RakotosaonaCentre national d'application de recherches pharmaceutiques, Ambodivoanjo, Antananarivo, Madagascar.
Ranjàna Hanitra RandrianarivoUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
Danielle Aurore Doll RakotoUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
Victor JeannodaUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
Arsène RatsimbasoaUniversité d'Antananarivo Faculté des sciences, Mention Biochimie fondamentale et appliquée, Madagascar.
University of Antananarivo · MGNational Application Center for Pharmaceutical Research · MG
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Background: Malaria is a parasitic disease caused by a hematozoan of the genus Methods: A total of 142 Results: The successful rates of amplification of Conclusion: Despite the limited number of samples analyzed, our study highlighted the circulation of isolates carrying both the mutant
Indexed as
ATP-Binding Cassette, Sub-Family C ProteinsMalaria, FalciparumMembrane Transport ProteinsPlasmodium falciparumProtozoan ProteinsAmodiaquineArtesunateChildChloroquineDrug ResistanceGenotypeHumansMadagascarPolymerase Chain ReactionPolymorphism, Restriction Fragment LengthAmodiaquineArtesunateATP-Binding Cassette, Sub-Family C ProteinsChloroquineMdr1 protein, Plasmodium falciparumMembrane Transport ProteinsPfCRT protein, Plasmodium falciparumProtozoan ProteinsAntimalarialChildrenIndian OceanMadagascarPfcrtPfmdr1Plasmodium falciparumResistanceVatomandry
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
[Pcr-rflp genotyping of · full record | OpenQuestion